JPRN-UMIN000011934已完成未知
The impact of additive EPA or ezetimibe to statin therapy on the stabilization of vulnerable plaque; Assessment by OCT - The impact of additive EPA or ezetimibe to statin therapy on the stabilization of vulnerable plaque; Assessment by OCT
Kobe University Graduate School of Medicine0 个研究点目标入组 80 人开始时间: 2013年10月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients were excluded from the study if they (1) were already using statins or other lipid-lowering therapies, (2) had known hypersensitivity to statins or contrast, (3) had end-stage renal failure (serum creatinine [Cre] ≥ 2.0 mg/dL), (4) demonstrated hemodynamic and respiratory instability (e.g., cardiogenic shock, severe congestive heart failure), or (5) had no consent to participate.
研究者
相似试验
进行中（未招募）
不适用
Effects of ezetimibe in association with statins on postprandial lipemia in type 2 diabetic patients - Ezetimibe effects on postprandial lipemiaEUCTR2008-000824-20-ITIVERSITA` DEGLI STUDI DI NAPOLI FEDERICO II
已完成
不适用
Effect of statin with ezetimibe versus statin alone on progression of coronary atherosclerotic plaque: Evaluate by Intravasclular ultrasound Virtual Histology and Optical Coherence TomographyIschemic heart diseaseJPRN-UMIN000005563Toyohashi Heart Ceter, Cardiovascular Medicine100
已完成
不适用
Recognized Effect of Statin and Ezetimibe therapy for achievement LDL-C Goaltype 2 diabetes mellitusJPRN-UMIN000002593Clinical study group for diabetes and dyslipidemia120
已完成
4 期
Ezetimibe and Statins on Postprandial Lipemia in Type 2 DiabetesPostprandial LipemiaType 2 DiabetesNCT00699023Federico II University13
已完成
不适用
Effects of Ezetimibe Add-On to Statin Therapy on Adipokine Production in Obese and Metabolic Syndrome Patients With AtherosclerosisMetabolic SyndromeObesityCoronary Artery DiseaseNCT00485121Canadian Collaborative Research Network50